Day One Biopharmaceuticals, Inc.DAWNNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
30.66%
↑ 207% above average
Average (22q)
-28.66%
Historical baseline
Range
High:125.81%
Low:-320.45%
Volatility
-1556.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 30.66% |
| Q2 2025 | 14.84% |
| Q1 2025 | 37.14% |
| Q4 2024 | -320.45% |
| Q3 2024 | 125.81% |
| Q2 2024 | -71.95% |
| Q1 2024 | -12.18% |
| Q4 2023 | -15.71% |
| Q3 2023 | -4.43% |
| Q2 2023 | -7.41% |
| Q1 2023 | -7.28% |
| Q4 2022 | -7.67% |
| Q3 2022 | -8.12% |
| Q2 2022 | -32.33% |
| Q1 2022 | -26.27% |
| Q4 2021 | -14.21% |
| Q3 2021 | -24.63% |
| Q2 2021 | 4.02% |
| Q1 2021 | -161.82% |
| Q4 2020 | -72.54% |
| Q3 2020 | -54.22% |
| Q2 2020 | -30.53% |
| Q1 2020 | 0.00% |